Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06486909

Shunt-dependency After aSAH - Role of Early Hyperglycaemia in CSF and Blood

Sponsor: Isabel Hostettler

View on ClinicalTrials.gov

Summary

The goal of this study is to confirm the association of early increased glucose levels in cerebro-spinal fluid (CSF) and ventriculo-peritoneal-shunt (VPS)-dependency also evaluating the influence of blood glucose on VPS dependency in patients suffering from an aneurysmal subarachnoid haemorrhage (aSAH). The main questions we aim to answer are: * Is there an association of glucose levels on VPS dependency in patients requiring extra-ventricular-drain (EVD) placement for aSAH? * In addition, if there is, what is the influence the course of glucose levels has on VPS dependency? Glucose levels in CSF and serum will be measured on admission, or in case of CSF, upon EVD placement. Glucose in CSF will then be measured every day until EVD removal together with serum glucose. Follow-up will be conducted in person after 3 and 6 months.

Official title: Shunt-dependency After Aneurysmal Subarachnoid Haemorrhage - the Role of Early Hyperglycaemia in Cerebro-spinal Fluid and Blood

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

160

Start Date

2024-03-26

Completion Date

2028-09

Last Updated

2026-03-18

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Cerebrospinal Fluid (CSF) Sample

Samples for glucose in CSF will be taken upon EVD/LD placement until EVD/LD removal (within the first 14 days).

DIAGNOSTIC_TEST

Blood Serum Sample

Samples for glucose in blood serum will be completed every day, for the first 14 days.

Locations (3)

Cantonal Hospital Aarau

Aarau, Switzerland

University Hospital Basel

Basel, Switzerland

Cantonal Hospital St Gallen

Sankt Gallen, Switzerland